Risk factors for resistance to β-lactam/β-lactamase inhibitors and ertapenem in Bacteroides bacteremia

Janessa M. Smith; Edina Avdic; Pranita D. Tamma; Long Zhang; Karen C. Carroll; Sara E. Cosgrove

doi:10.1128/AAC.00046-15

Risk factors for resistance to β-lactam/β-lactamase inhibitors and ertapenem in Bacteroides bacteremia

Janessa M. Smith, Edina Avdic, Pranita D. Tamma, Long Zhang, Karen C. Carroll, Sara E. Cosgrove

School of Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The objective of this study was to determine risk factors for the development of resistance to β-lactams/β-lactamase inhibitors (βL/βLIs) and ertapenem among Bacteroides species bacteremia. We conducted a retrospective case-control study of 101 adult patients with Bacteroides species bacteremia at a 1,051-bed tertiary care medical center. The duration of exposure to βL/βLIs (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.08 to 2.31) was the only independent risk factor for resistance.

Original language	English (US)
Pages (from-to)	5049-5051
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	59
Issue number	8
DOIs	https://doi.org/10.1128/AAC.00046-15
State	Published - Aug 1 2015

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.00046-15

Cite this

@article{1bb620a21a814d4c9828dee570710810,

title = "Risk factors for resistance to β-lactam/β-lactamase inhibitors and ertapenem in Bacteroides bacteremia",

abstract = "The objective of this study was to determine risk factors for the development of resistance to β-lactams/β-lactamase inhibitors (βL/βLIs) and ertapenem among Bacteroides species bacteremia. We conducted a retrospective case-control study of 101 adult patients with Bacteroides species bacteremia at a 1,051-bed tertiary care medical center. The duration of exposure to βL/βLIs (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.08 to 2.31) was the only independent risk factor for resistance.",

author = "Smith, {Janessa M.} and Edina Avdic and Tamma, {Pranita D.} and Long Zhang and Carroll, {Karen C.} and Cosgrove, {Sara E.}",

year = "2015",

month = aug,

day = "1",

doi = "10.1128/AAC.00046-15",

language = "English (US)",

volume = "59",

pages = "5049--5051",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

TY - JOUR

T1 - Risk factors for resistance to β-lactam/β-lactamase inhibitors and ertapenem in Bacteroides bacteremia

AU - Smith, Janessa M.

AU - Avdic, Edina

AU - Tamma, Pranita D.

AU - Zhang, Long

AU - Carroll, Karen C.

AU - Cosgrove, Sara E.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The objective of this study was to determine risk factors for the development of resistance to β-lactams/β-lactamase inhibitors (βL/βLIs) and ertapenem among Bacteroides species bacteremia. We conducted a retrospective case-control study of 101 adult patients with Bacteroides species bacteremia at a 1,051-bed tertiary care medical center. The duration of exposure to βL/βLIs (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.08 to 2.31) was the only independent risk factor for resistance.

AB - The objective of this study was to determine risk factors for the development of resistance to β-lactams/β-lactamase inhibitors (βL/βLIs) and ertapenem among Bacteroides species bacteremia. We conducted a retrospective case-control study of 101 adult patients with Bacteroides species bacteremia at a 1,051-bed tertiary care medical center. The duration of exposure to βL/βLIs (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.08 to 2.31) was the only independent risk factor for resistance.

UR - http://www.scopus.com/inward/record.url?scp=84939865005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939865005&partnerID=8YFLogxK

U2 - 10.1128/AAC.00046-15

DO - 10.1128/AAC.00046-15

M3 - Article

C2 - 26033720

AN - SCOPUS:84939865005

SN - 0066-4804

VL - 59

SP - 5049

EP - 5051

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 8

ER -

Risk factors for resistance to β-lactam/β-lactamase inhibitors and ertapenem in Bacteroides bacteremia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this